Elsevier

Pancreatology

Volume 5, Issue 6, 2005, Pages 514-529
Pancreatology

Role of inflammation in pancreatic carcinogenesis and the implications for future therapy

https://doi.org/10.1159/000087493Get rights and content

Abstract

Background: The link between inflammation and pancreatic cancer has been observed for a number of gastrointestinal neoplasms. This review examines the role of inflammation in pancreatic carcinogenesis and how it can be utilised to develop new therapies against pancreatic cancer. Methods: A literature review of Pubmed, Medline and Web of Science databases was undertaken using the key words, pancreatic cancer, inflammation, inducible nitric oxide, interleukins, pro-inflammatory cytokines, cyclooxygenase-2, NF-kappa B, reactive oxygen species, DNA adducts, lipoxygenases, chemoprevention. Results: Epidemiological evidence and molecular studies both in vitro and in vivo all support the hypothesis that inflammation plays an important in the initiation and progression of pancreatic tumours. Conclusion: Sustained damage caused by chronic inflammation may precede the onset of frank malignancy by a significant interval. As such, suppression of inflammatory changes and oxidative damage, may help delay or even prevent the inception of pancreatic neoplasia.

References (194)

  • RM Schmid et al.

    NF-kappaB/Rel/Ikap-paB: implications in gastrointestinal diseases

    Gastroenterology

    (2000)
  • R Brew et al.

    Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro

    Cytokine

    (2000)
  • BN Fahy et al.

    Inhibition of AKT abrogates chemotherapy-induced NF-KB survival mechanisms: implications for therapy in pancreatic cancer

    J Am Coll Surg

    (2004)
  • RP Thomas et al.

    Selective targeting of the nuclear factor-kappaB pathway enhances tumour necrosis factor-related apoptosis-inducing ligand-mediated pancreatic cancer cell death

    Surgery

    (2002)
  • TP McDade et al.

    Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells

    J Surg Res

    (1999)
  • SM Prescott et al.

    Cyclooxygenase-2 and carcinogenesis

    Biochim Biophys Acta

    (2000)
  • CE Eberhart et al.

    Upregulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

    Gastroenterology

    (1994)
  • G Eibl et al.

    PGE2 is generated by specific COX-2 activity and increases VEGF production in COX-2-expressing human pancreatic cancer cells

    Biochem Biophys Res Commun

    (2003)
  • FA Wenger et al.

    Effects of Celebrex and Zyflo on BOP-induced pancreatic cancer in Syrian hamsters

    Pancreatology

    (2002)
  • SS Devesa et al.

    Recent cancer trends in the United States

    J Natl Cancer Inst

    (1995)
  • JP Duffy et al.

    Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer

    Molec Cancer

    (2003)
  • AL Warshaw et al.

    Preoperative staging and assessment of resectability of pancreatic cancer

    Archs Surg

    (1990)
  • T Rohan et al.

    Alimentary tract cancer mortality in Australia, 1908ā€“1978. An epidemiological appraisal

    Med J Aust

    (1981)
  • F Levi et al.

    Trends in cancer mortality in Switzerland, 1951-1984

    Rev Epidemiol SantƩ Publ

    (1988)
  • KD Lilliemoe et al.

    Pancreatic cancer: state-of-the-art care

    Can Cancer J Clin

    (2000)
  • P Boyle et al.

    Cigarette smoking and pancreas cancer: a case control study of the search programme of the IARC

    Int J Cancer

    (1996)
  • E Weiderpass et al.

    Occupational exposures and gastrointestinal cancers among Finnish women

    J Occup Environ Med

    (2003)
  • DJ Garabant et al.

    DDT and related compounds and risk of pancreatic cancer

    J Natl Cancer Inst

    (1992)
  • A Anttila et al.

    Cancer incidence among Finnish workers exposed to halogenated hydrocarbons

    J Occup Environ Med

    (1995)
  • AC Tersmette et al.

    Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer

    Clin Cancer Res

    (2001)
  • P Ghadrian et al.

    Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas

    Int J Cancer

    (2002)
  • RH Hruban et al.

    Prevention of pancreatic cancer and strategies for management of pancreatic cancer

    Dig Dis

    (2001)
  • M Raderer et al.

    Association between Helicobacter pylori infection and pancreatic cancer

    Oncology

    (1998)
  • G Rocca et al.

    Increased incidence of cancer in chronic pancreatitis

    Jf Clin Gastroenterol

    (1987)
  • M Otsuki

    Chronic pancreatitis in Japan: epidemiology, prognosis, diagnostic criteria, and future problems

    J Gastroenterol

    (2003)
  • P Maisonnneuve et al.

    Chronic pancreatitis and pancreatic cancer

    Dig Dis

    (2002)
  • A.J. M Ekbom et al.

    Pancreatitis and pancreatic cancer: a population based study

    J Natn Cancer Inst

    (1994)
  • AB Lowenfels et al.

    Pancreatitis and the risk of pancreatic cancer

    N Engl J Med

    (1993)
  • AB Lowenfels et al.

    Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group

    J Natn Cancer Inst

    (1997)
  • DC Whitcomb et al.

    Hereditary pancreatitis and the risk of pancreatic carcinoma

    Ann NY Acad Sci

    (1999)
  • R Ammann et al.

    High incidence of extrapancreatic carcinoma in patients with chronic pancreatitis

    Scand J Gastroenterol

    (1980)
  • G Talamini et al.

    Cigarette smoking: an independent risk factor in alcoholic pancreatitis

    Pancreas

    (1996)
  • W Schlosser et al.

    Cyclooxygen-ase-2 is overexpressed in chronic pancreatitis

    Pancreas

    (2002)
  • D Basso et al.

    Lipid peroxidation and renal tubular damage in chronic pancreatic diseases: is there any relationship

    J Med

    (1994)
  • D Basso et al.

    Oxygen derived free radicals in patients with chronic pancreatitis and other digestive diseases

    J Clin Pathol

    (1990)
  • AS Baldwin

    The NF-kappaB and I kappaB proteins: new discoveries and insights

    Ann Rev Immunol

    (1996)
  • H Yamamoto et al.

    Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer

    J Clin Invest

    (2001)
  • Q Shi et al.

    Cooperation between transcription factor AP-1 and NF-kappaB in the induction of interleukin-8 in human pancreatic adenocarcinoma cells by hypoxia

    J Interferon Cytokine Res

    (1999)
  • S Liptay et al.

    Mitogenic and antiapoptotic role of constitutive NF-KB/Rel activity in pancreatic cancer

    Int J Cancer

    (2003)
  • W Wang et al.

    The nuclear factor-KB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells

    Clin Cancer Res

    (1999)
  • Cited by (110)

    • Pancreatic cancer: A critical review of dietary risk

      2018, Nutrition Research
      Citation Excerpt :

      Vitamin C is known for its antioxidant, immune boosting properties [10]. Given that inflammation and oxidative stress may play a role in pancreatic carcinogenesis [11,12], it is biologically plausible that vitamin C may mitigate this process. In addition, vitamin C can induce apoptosis and inhibit neoplastic lesions in the pancreas [13,14].

    • Does the vaginal microbiota play a role in the development of cervical cancer?

      2017, Translational Research
      Citation Excerpt :

      The infection of the basal membrane of the mucosal surfaces by HPV initiates a cascade of mediated mechanism related to inflammation, activation of the mucosal immunity with proinflammatory cytokines, interferons, activation of macrophages and NK cells, and the integration of the viral DNA. All these inflammatory processes and changes in the immune and mucosal environment may in turn impact on the VM.107-111 Interestingly, this similar increase in diversity and low Lactobacilli has also been associated with HIV acquisition.112

    View all citing articles on Scopus
    *

    Giuseppe Garcea, MD Cancer Studies and Molecular Medicine, 5th Floor The Robert Kilpatrick Clinical Sciences Building, The Leicester Royal Infirmary Leicester, LE2 7LX (UK) Tel. +44 116 258 4666, Fax +44 116 258 4708

    View full text